Leerink Partnrs Comments on AbbVie’s Q1 Earnings (NYSE:ABBV)
AbbVie Inc. (NYSE:ABBV – Free Report) – Equities researchers at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for shares of AbbVie in a research report issued to clients and investors on Monday, April 21st. Leerink Partnrs analyst D. Risinger forecasts that the company will post earnings per share of $2.37 for […]
AbbVie Inc. (NYSE:ABBV – Free Report) – Equities researchers at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for shares of AbbVie in a research report issued to clients and investors on Monday, April 21st. Leerink Partnrs analyst D. Risinger forecasts that the company will post earnings per share of $2.37 for […]
